Global Fragment-based Drug Discovery Market Research Report 2024(Status and Outlook)
Report Overview:
The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.
The Global Fragment-based Drug Discovery Market Size was estimated at USD 366.60 million in 2023 and is projected to reach USD 534.92 million by 2029, exhibiting a CAGR of 6.50% during the forecast period.
This report provides a deep insight into the global Fragment-based Drug Discovery market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Fragment-based Drug Discovery Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Fragment-based Drug Discovery market in any manner.
Global Fragment-based Drug Discovery Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Astex Pharmaceuticals
Alveus Pharmaceuticals
Beactica
Charles River Laboratories
Crown Bioscience
Emerald BioStructures
Evotec
Kinetic Discovery
Proteros Fragments
Sprint Bioscience
Structure Based Design
Sygnature Discovery
Market Segmentation (by Type)
Fragment Screening
Fragment Optimization
Market Segmentation (by Application)
Academic and Research Institutions
Biopharmaceutical Companies
Contract Research Organizations (CROs)
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Fragment-based Drug Discovery Market
Overview of the regional outlook of the Fragment-based Drug Discovery Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Fragment-based Drug Discovery Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Fragment-based Drug Discovery
- 1.2 Key Market Segments
- 1.2.1 Fragment-based Drug Discovery Segment by Type
- 1.2.2 Fragment-based Drug Discovery Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Fragment-based Drug Discovery Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Fragment-based Drug Discovery Market Size (M USD) Estimates and Forecasts (2019-2030)
- 2.1.2 Global Fragment-based Drug Discovery Sales Estimates and Forecasts (2019-2030)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Fragment-based Drug Discovery Market Competitive Landscape
- 3.1 Global Fragment-based Drug Discovery Sales by Manufacturers (2019-2024)
- 3.2 Global Fragment-based Drug Discovery Revenue Market Share by Manufacturers (2019-2024)
- 3.3 Fragment-based Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Fragment-based Drug Discovery Average Price by Manufacturers (2019-2024)
- 3.5 Manufacturers Fragment-based Drug Discovery Sales Sites, Area Served, Product Type
- 3.6 Fragment-based Drug Discovery Market Competitive Situation and Trends
- 3.6.1 Fragment-based Drug Discovery Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Fragment-based Drug Discovery Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Fragment-based Drug Discovery Industry Chain Analysis
- 4.1 Fragment-based Drug Discovery Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Fragment-based Drug Discovery Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Fragment-based Drug Discovery Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Fragment-based Drug Discovery Sales Market Share by Type (2019-2024)
- 6.3 Global Fragment-based Drug Discovery Market Size Market Share by Type (2019-2024)
- 6.4 Global Fragment-based Drug Discovery Price by Type (2019-2024)
- 7 Fragment-based Drug Discovery Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Fragment-based Drug Discovery Market Sales by Application (2019-2024)
- 7.3 Global Fragment-based Drug Discovery Market Size (M USD) by Application (2019-2024)
- 7.4 Global Fragment-based Drug Discovery Sales Growth Rate by Application (2019-2024)
- 8 Fragment-based Drug Discovery Market Segmentation by Region
- 8.1 Global Fragment-based Drug Discovery Sales by Region
- 8.1.1 Global Fragment-based Drug Discovery Sales by Region
- 8.1.2 Global Fragment-based Drug Discovery Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Fragment-based Drug Discovery Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Fragment-based Drug Discovery Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Fragment-based Drug Discovery Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Fragment-based Drug Discovery Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Fragment-based Drug Discovery Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Astex Pharmaceuticals
- 9.1.1 Astex Pharmaceuticals Fragment-based Drug Discovery Basic Information
- 9.1.2 Astex Pharmaceuticals Fragment-based Drug Discovery Product Overview
- 9.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Product Market Performance
- 9.1.4 Astex Pharmaceuticals Business Overview
- 9.1.5 Astex Pharmaceuticals Fragment-based Drug Discovery SWOT Analysis
- 9.1.6 Astex Pharmaceuticals Recent Developments
- 9.2 Alveus Pharmaceuticals
- 9.2.1 Alveus Pharmaceuticals Fragment-based Drug Discovery Basic Information
- 9.2.2 Alveus Pharmaceuticals Fragment-based Drug Discovery Product Overview
- 9.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Product Market Performance
- 9.2.4 Alveus Pharmaceuticals Business Overview
- 9.2.5 Alveus Pharmaceuticals Fragment-based Drug Discovery SWOT Analysis
- 9.2.6 Alveus Pharmaceuticals Recent Developments
- 9.3 Beactica
- 9.3.1 Beactica Fragment-based Drug Discovery Basic Information
- 9.3.2 Beactica Fragment-based Drug Discovery Product Overview
- 9.3.3 Beactica Fragment-based Drug Discovery Product Market Performance
- 9.3.4 Beactica Fragment-based Drug Discovery SWOT Analysis
- 9.3.5 Beactica Business Overview
- 9.3.6 Beactica Recent Developments
- 9.4 Charles River Laboratories
- 9.4.1 Charles River Laboratories Fragment-based Drug Discovery Basic Information
- 9.4.2 Charles River Laboratories Fragment-based Drug Discovery Product Overview
- 9.4.3 Charles River Laboratories Fragment-based Drug Discovery Product Market Performance
- 9.4.4 Charles River Laboratories Business Overview
- 9.4.5 Charles River Laboratories Recent Developments
- 9.5 Crown Bioscience
- 9.5.1 Crown Bioscience Fragment-based Drug Discovery Basic Information
- 9.5.2 Crown Bioscience Fragment-based Drug Discovery Product Overview
- 9.5.3 Crown Bioscience Fragment-based Drug Discovery Product Market Performance
- 9.5.4 Crown Bioscience Business Overview
- 9.5.5 Crown Bioscience Recent Developments
- 9.6 Emerald BioStructures
- 9.6.1 Emerald BioStructures Fragment-based Drug Discovery Basic Information
- 9.6.2 Emerald BioStructures Fragment-based Drug Discovery Product Overview
- 9.6.3 Emerald BioStructures Fragment-based Drug Discovery Product Market Performance
- 9.6.4 Emerald BioStructures Business Overview
- 9.6.5 Emerald BioStructures Recent Developments
- 9.7 Evotec
- 9.7.1 Evotec Fragment-based Drug Discovery Basic Information
- 9.7.2 Evotec Fragment-based Drug Discovery Product Overview
- 9.7.3 Evotec Fragment-based Drug Discovery Product Market Performance
- 9.7.4 Evotec Business Overview
- 9.7.5 Evotec Recent Developments
- 9.8 Kinetic Discovery
- 9.8.1 Kinetic Discovery Fragment-based Drug Discovery Basic Information
- 9.8.2 Kinetic Discovery Fragment-based Drug Discovery Product Overview
- 9.8.3 Kinetic Discovery Fragment-based Drug Discovery Product Market Performance
- 9.8.4 Kinetic Discovery Business Overview
- 9.8.5 Kinetic Discovery Recent Developments
- 9.9 Proteros Fragments
- 9.9.1 Proteros Fragments Fragment-based Drug Discovery Basic Information
- 9.9.2 Proteros Fragments Fragment-based Drug Discovery Product Overview
- 9.9.3 Proteros Fragments Fragment-based Drug Discovery Product Market Performance
- 9.9.4 Proteros Fragments Business Overview
- 9.9.5 Proteros Fragments Recent Developments
- 9.10 Sprint Bioscience
- 9.10.1 Sprint Bioscience Fragment-based Drug Discovery Basic Information
- 9.10.2 Sprint Bioscience Fragment-based Drug Discovery Product Overview
- 9.10.3 Sprint Bioscience Fragment-based Drug Discovery Product Market Performance
- 9.10.4 Sprint Bioscience Business Overview
- 9.10.5 Sprint Bioscience Recent Developments
- 9.11 Structure Based Design
- 9.11.1 Structure Based Design Fragment-based Drug Discovery Basic Information
- 9.11.2 Structure Based Design Fragment-based Drug Discovery Product Overview
- 9.11.3 Structure Based Design Fragment-based Drug Discovery Product Market Performance
- 9.11.4 Structure Based Design Business Overview
- 9.11.5 Structure Based Design Recent Developments
- 9.12 Sygnature Discovery
- 9.12.1 Sygnature Discovery Fragment-based Drug Discovery Basic Information
- 9.12.2 Sygnature Discovery Fragment-based Drug Discovery Product Overview
- 9.12.3 Sygnature Discovery Fragment-based Drug Discovery Product Market Performance
- 9.12.4 Sygnature Discovery Business Overview
- 9.12.5 Sygnature Discovery Recent Developments
- 10 Fragment-based Drug Discovery Market Forecast by Region
- 10.1 Global Fragment-based Drug Discovery Market Size Forecast
- 10.2 Global Fragment-based Drug Discovery Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Fragment-based Drug Discovery Market Size Forecast by Country
- 10.2.3 Asia Pacific Fragment-based Drug Discovery Market Size Forecast by Region
- 10.2.4 South America Fragment-based Drug Discovery Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Fragment-based Drug Discovery by Country
- 11 Forecast Market by Type and by Application (2025-2030)
- 11.1 Global Fragment-based Drug Discovery Market Forecast by Type (2025-2030)
- 11.1.1 Global Forecasted Sales of Fragment-based Drug Discovery by Type (2025-2030)
- 11.1.2 Global Fragment-based Drug Discovery Market Size Forecast by Type (2025-2030)
- 11.1.3 Global Forecasted Price of Fragment-based Drug Discovery by Type (2025-2030)
- 11.2 Global Fragment-based Drug Discovery Market Forecast by Application (2025-2030)
- 11.2.1 Global Fragment-based Drug Discovery Sales (K Units) Forecast by Application
- 11.2.2 Global Fragment-based Drug Discovery Market Size (M USD) Forecast by Application (2025-2030)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook